PEMETREXED AND CARBOPLATIN VERSUS DOCETAXEL AND CARBOPLATIN AS FIRST-LINE TREATMENT FOR PATIENTS WITH ADVANCED, NON-SQUAMOUS, NON-SMALL CELL LUNG CANCER (NSCLC)

被引：0
|
作者：
Ganju, Vinod [1 ]
Pereira, Jose [2 ]
Kim, Joo-Hang [3 ]
Magallanes, Manuel [4 ]
Lee, Dae-Ho [5 ]
Wang, Jie [6 ]
Martinez, Luis [7 ]
Barraclough, Helen
Van Kooten, Maximiliano
Orlando, Mauro
机构：
[1] Frankston Private Hosp, Peninsula Oncol Ctr, Frankston, Vic, Australia
[2] Inst Arnaldo Vieira De Carvalho, Oncopneumol Dept, Sao Paulo, Brazil
[3] Yonsei Canc Ctr, Seoul, South Korea
[4] Mil Hosp Mexico, Dept Med Oncol, Mexico City, DF, Mexico
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Ulsan, South Korea
[6] Beijing Canc Hosp & Inst, Dept Thorac Oncol, Beijing, Peoples R China
[7] Natl Inst Resp Dis, Dept Oncol, Mexico City, DF, Mexico
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
Pemetrexed; Docetaxel; Non-squamous nsmall cell lung cancer; Carboplatin;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S417 / S418
页数：2
相关论文
共 50 条
  • [1] Pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for advanced non-squamous non-small cell lung cancer (NSCLC)
    Patel, J. D.
    Hensing, T. A.
    Rademaker, F.
    Hart, E.
    Obasaju, C. K.
    Treat, J.
    Milton, D.
    Bonomi, P. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] First-Line Carboplatin, Pemetrexed, and Panitumumab in Patients with Advanced Non-Squamous KRAS Wild Type (WT) Non-Small-Cell Lung Cancer (NSCLC)
    Spigel, David R.
    Mekhail, Tarek M.
    Waterhouse, David
    Hadley, Terence
    Webb, Charles
    Burris, Howard A.
    Hainsworth, John D.
    Greco, F. Anthony
    CANCER INVESTIGATION, 2017, 35 (08) : 541 - 546
  • [3] Pemetrexed-Carboplatin Versus Paclitaxel (Weekly)-Carboplatin as First Line Chemotherapy in Advanced Non-Squamous NSCLC
    Malik, P.
    Yadav, A.
    Jain, D.
    Pathy, S.
    Mohan, A.
    Khurana, S.
    Kumar, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S354 - S355
  • [4] Pemetrexed and carboplatin plus bevacizumab for advanced non-squamous non-small cell lung cancer (NSCLC): Preliminary results
    Patel, J. D.
    Hensing, T. A.
    Villafor, V.
    Hart, E.
    Bonomi, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer
    Rodrigues-Pereira, Jose
    Kim, Joo-Hang
    Magallanes, Manuel
    Lee, Dae Ho
    Wang, Jie
    Ganju, Vinod
    Martinez-Barrera, Luis
    Barraclough, Helen
    van Kooten, Maximiliano
    Orlando, Mauro
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) : 1907 - 1914
  • [6] Analysis of continuous first-line treatment with docetaxel and carboplatin for advanced non-small cell lung cancer
    Aoki, Takuya
    Ebihara, Akinori
    Yogo, Yurika
    Suemasu, Keiichi
    Sakamaki, Fumio
    ONCOLOGY LETTERS, 2014, 7 (06) : 1771 - 1777
  • [7] A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer
    Tamiya, Motohiro
    Tamiya, Akihiro
    Kaneda, Hiroyasu
    Nakagawa, Kazuhiko
    Yoh, Kiyotaka
    Goto, Koichi
    Okamoto, Hiroaki
    Shimokawa, Tsuneo
    Abe, Tetsuya
    Tanaka, Hiroshi
    Daga, Haruko
    Takeda, Koji
    Hirashima, Tomonori
    Atagi, Shinji
    MEDICAL ONCOLOGY, 2016, 33 (01) : 1 - 7
  • [8] A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer
    Motohiro Tamiya
    Akihiro Tamiya
    Hiroyasu Kaneda
    Kazuhiko Nakagawa
    Kiyotaka Yoh
    Koichi Goto
    Hiroaki Okamoto
    Tsuneo Shimokawa
    Tetsuya Abe
    Hiroshi Tanaka
    Haruko Daga
    Koji Takeda
    Tomonori Hirashima
    Shinji Atagi
    Medical Oncology, 2016, 33
  • [9] An extended overall survival analysis of pemetrexed and carboplatin with or without pembrolizumab as first-line therapy for advanced non-squamous non-small cell lung cancer
    Afzal, Muhammad Zubair
    Dragnev, Konstantin H.
    Shirai, Keisuke
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [10] Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab with Maintenance Bevacizumab as a First-line Treatment for Advanced Non-squamous Non-small Cell Lung Cancer in Elderly Patients
    Takeoka, Hiroaki
    Yamada, Kazuhiko
    Naito, Yoshiko
    Matsuo, Norikazu
    Ishii, Hidenobu
    Tokito, Takaaki
    Azuma, Koichi
    Ichiki, Masao
    Hoshino, Tomoaki
    ANTICANCER RESEARCH, 2018, 38 (06) : 3779 - 3784
12345